Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108672772 | 10867277 | 2 | F | 20160719 | 20150225 | 20160719 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-012400 | BRISTOL MYERS SQUIBB | 15.00 | YR | M | Y | 0.00000 | 20160719 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108672772 | 10867277 | 1 | PS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Unknown | 5 MG, QD | U | 21436 | 5 | MG | QD | ||||||
| 108672772 | 10867277 | 2 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Unknown | 15 MG, QD | U | 21436 | 15 | MG | QD | ||||||
| 108672772 | 10867277 | 3 | C | METHYLPHENIDATE. | METHYLPHENIDATE | 1 | Unknown | U | 0 | ||||||||||
| 108672772 | 10867277 | 4 | C | GUANFACINE. | GUANFACINE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108672772 | 10867277 | 1 | Mood swings |
| 108672772 | 10867277 | 2 | Aggression |
| 108672772 | 10867277 | 3 | Attention deficit/hyperactivity disorder |
| 108672772 | 10867277 | 4 | Attention deficit/hyperactivity disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108672772 | 10867277 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |